Character Biosciences

Jersey City, United States

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

$17.0M raised

Sep 2025

Series B

Artificial Intelligence (AI)Biotechnology Clinical Trials Health Care Health Diagnostics

Top Investors

Industry Ventures Catalio Capital Management Sanofi Ventures S32 Cantos

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Character Biosciences

How much funding has Character Biosciences raised?

Character Biosciences has raised $17.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.

Who are Character Biosciences's investors?

Character Biosciences's investors include Industry Ventures, Catalio Capital Management, Sanofi Ventures, S32, Cantos.

Where is Character Biosciences headquartered?

Character Biosciences is headquartered in Jersey City, United States.

What does Character Biosciences do?

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

What stage is Character Biosciences at?

Character Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2025.

MLA

"Character Biosciences — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/character-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2025). Character Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/character-biosciences

Wikipedia (cite web)

{{cite web |title=Character Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/character-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2025.